WEBINAR: The one test every cancer patient should know
Register to Attend Online (Free)
Just over five years ago, the FDA approved the first comprehensive NextGeneration Sequencing tests.
This test takes a pieces of a person’s actual tumor and analyzes the genetic mutations. When we talk of personalized treatment, this is it.
We believe all high-risk cancer patients should get NextGeneration tumor sequencing.
In this webinar, we discuss what makes a patient high-risk, what the test does for patients, and how to get it.
You may know the test by other names:
- Genetic Analysis
- Molecular Profiling
- Tumor Sequencing
- Biomarker Testing
- Genomic Testing
- Next Generation (NextGen) Sequencing
Essentially they are all the same in that they look at the DNA makeup of a patient's cancer. And for nearly every patient, this is different and can guide them to the best cancer care possible.
CHAPTERS
0:00 Introduction
0:37 What is the one test that every single cancer patient should know?
4:27 What are gene mutations like BRAC?
6:04 What makes it NextGen sequencing?
8:01 Who should get NextGen sequencing?
11:53 How do you get NextGen sequencing done and get the report?
14:10 How Does this affect treatment decisions?
15:34 How else is tumor sequencing helpful to cancer patients?
18:04 Why aren’t more cancer patients getting this test done?
19:23 When and how do you ask your oncologist about this?
23:47 What to do if no tumor tissue is available (circulating tumor DNA test)
25:17 What to do if your oncologist won’t order the test?
26:28 What test is best (any that test as much as possible)?
27:55 Why my oncologist tells me that the report won’t change my treatment?
29:09 Matching to clinical trials from NextGen sequencing.
